Sunday, 17 October 2021
Vaccine pharmacovigilance is a critical aspect in public health and a key indicator for pharmacovigilance systems. The MCAZ in collaboration with the Expanded Programme on Immunization- Ministry of Health and Child Care (EPI-MoHCC), have continuously worked to develop vaccine pharmacovigilance in Zimbabwe through participation in World Health Organisation (WHO) projects, development and implementation of the Adverse Events Following Immunization (AEFI) surveillance guidelines and conducting trainings for health care professionals on AEFI reporting and case investigations.
To download all forms associated with Vaccine Safety including the WHO Vaccine Safety Fact Sheets click here
Brighton Collaboration - Case Definitions
How to Arrange Vaccines Inside Any Refrigerator
What Health Workers Must Do to Maintain the Cold Chain
How to Assess Possible Contraindications
Adverse Events Following Immunization Surveillance Guidelines
This Site includes links to third party web sites which are not maintained by MCAZ. MCAZ does not review, endorse or approve the third party sites and is not responsible for their content. You agree that linking to or using the third party sites is at your sole risk and that MCAZ will not be liable for any loss or damages arising from your use of those sites. MCAZ will not be responsible for information provided to you on the Other Sites.
The Medicines Control Authority of Zimbabwe (MCAZ) is the statutory body responsible for protecting public and animal health by ensuring that all medicines, devices, allied substances, and other health commodities...
In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical......
The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...
Guidance on submission of covid-19 vaccine applications for emergency use authorisation and registration have been published. Click MCAZ COVID-19 VACCINE GUIDANCE-VERSION 11 download the guideline.
In order to improve service delivery to our valued customers, MCAZ collects information on Customer Complaints. To download the 2019 Customer Complaints Trends Analysis Click here
The Medicines Control Authority of Zimbabwe (MCAZ) Covid-19 Health and Safety Guidelines applies to MCAZ staff with the intention of preventing workplace infections, protecting lives, and promoting employee health for...
The draft Blood and Blood Components Regulations are now available Please note that this is a DRAFT that has been uploaded to obtain comments from stakeholders before the regulations are...
This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat orcure COVID-19. Medical...
Draft SADC Variations Guidelines are now available Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet
Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...